News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
700,506 Results
Type
Article (41569)
Company Profile (463)
Press Release (658474)
Section
Business (208385)
Career Advice (2002)
Deals (35940)
Drug Delivery (92)
Drug Development (83284)
Employer Resources (169)
FDA (16325)
Job Trends (15043)
News (352058)
Policy (32976)
Tag
Academia (2619)
Alliances (50582)
Alzheimer's disease (1270)
Approvals (16245)
Artificial intelligence (134)
Bankruptcy (361)
Best Places to Work (11727)
Biotechnology (349)
Breast cancer (120)
Cancer (1064)
Cardiovascular disease (90)
Career advice (1671)
Cell therapy (236)
Clinical research (65880)
Collaboration (385)
Compensation (190)
COVID-19 (2588)
C-suite (92)
Data (1060)
Diabetes (154)
Diagnostics (6190)
Earnings (86022)
Employer resources (147)
Events (112795)
Executive appointments (285)
FDA (16838)
Funding (344)
Gene therapy (185)
GLP-1 (608)
Government (4407)
Healthcare (18990)
Infectious disease (2670)
Inflammatory bowel disease (111)
Interviews (308)
IPO (16560)
Job creations (3694)
Job search strategy (1428)
Layoffs (439)
Legal (7926)
Lung cancer (169)
Manufacturing (175)
Medical device (13317)
Medtech (13322)
Mergers & acquisitions (19427)
Metabolic disorders (414)
Neuroscience (1541)
NextGen Class of 2024 (6733)
Non-profit (4531)
Northern California (1432)
Obesity (240)
Opinion (197)
Patents (99)
People (57562)
Phase I (20637)
Phase II (29079)
Phase III (21513)
Pipeline (445)
Postmarket research (2590)
Preclinical (8861)
Radiopharmaceuticals (250)
Rare diseases (221)
Real estate (5997)
Regulatory (21932)
Research institute (2403)
Resumes & cover letters (351)
Southern California (1287)
Startups (3745)
United States (13429)
Vaccines (564)
Weight loss (181)
Date
Last 7 days (935)
Last 30 days (3544)
Last 365 days (36474)
2024 (33080)
2023 (41013)
2022 (52276)
2021 (56765)
2020 (54924)
2019 (47419)
2018 (35697)
2017 (33024)
2016 (32346)
2015 (38396)
2014 (32185)
2013 (27109)
2012 (29220)
2011 (29863)
2010 (27992)
Location
Africa (731)
Arizona (198)
Asia (38475)
Australia (6395)
California (3281)
Canada (1261)
China (241)
Colorado (145)
Connecticut (153)
Europe (83912)
Florida (441)
Georgia (112)
Illinois (349)
Indiana (193)
Kansas (99)
Maryland (581)
Massachusetts (2642)
Michigan (155)
Minnesota (274)
New Jersey (938)
New York (942)
North Carolina (747)
Northern California (1432)
Ohio (135)
Pennsylvania (824)
South America (1105)
Southern California (1287)
Texas (450)
Utah (90)
Washington State (365)
700,506 Results for "arcturus therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Arcturus Therapeutics Appoints Moncef Slaoui, Ph.D., to Board of Directors
Arcturus Therapeutics Holdings Inc. today announced the appointment of a new independent director, Moncef Slaoui, Ph.D., to the Company’s Board of Directors.
June 20, 2024
·
5 min read
Biotech Beach
Arcturus Therapeutics Announces Positive Development for Cystic Fibrosis Program
Arcturus Therapeutics Holdings Inc. announced Arcturus will be presenting Phase 1 results in healthy volunteers and new Phase 1b interim data in CF patients for ARCT-032, an inhaled investigational mRNA therapeutic to treat CF, at the 47th European Cystic Fibrosis Conference on June 7, 2024.
May 28, 2024
·
5 min read
Biotech Beach
Arcturus Therapeutics to Attend Upcoming Investor & Scientific Conferences - May 15, 2024
Arcturus Therapeutics Holdings Inc. announced that the Company will participate in the following investor and scientific conferences.
May 15, 2024
·
2 min read
Press Releases
Arcturus Therapeutics Announces Third Quarter 2024 Financial Update and Pipeline Progress
November 7, 2024
·
14 min read
Biotech Beach
Arcturus Therapeutics Presents New Clinical Data at 47th Annual European Cystic Fibrosis Conference
Arcturus Therapeutics Presents New Clinical Data at 47th Annual European Cystic Fibrosis Conference.
June 7, 2024
·
7 min read
Press Releases
Arcturus Therapeutics to Report Third Quarter Financial Results and Provide Corporate Update on November 7, 2024
October 31, 2024
·
1 min read
Business
Arcturus Therapeutics Announces First Quarter 2024 Financial Update and Pipeline Progress
Arcturus Therapeutics Holdings Inc., a global messenger RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases, announced its financial results for the first quarter ended March 31, 2024, and provided corporate updates.
May 8, 2024
·
13 min read
Biotech Beach
Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 8, 2024
Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT) today announced that it will release its financial results for the quarter ended March 31, 2024 after the market close on Wednesday, May 8 and will also host a conference call and webcast at 4:30 pm Eastern Time on May 8, 2024.
April 25, 2024
·
2 min read
Press Releases
Arcturus Therapeutics Receives Clearance from FDA to Begin H5N1 Pandemic Flu Vaccine Clinical Trial
November 12, 2024
·
4 min read
Business
Arcturus Therapeutics Announces Fourth Quarter and Fiscal Year 2023 Financial Update and Pipeline Progress
Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT) today announced its financial results for the fourth quarter ended December 31, 2023, and provided corporate updates.
March 7, 2024
·
15 min read
1 of 70,051
Next
